BiotechTube
Discover
News
Company
Sign in
BiotechTube
Home
/
Targepeutics
/
Sil Lutkewitte
SL
Sil Lutkewitte
CEO, Chair - Board of Directors
Targepeutics
Therapeutic Areas
Oncology
Neuro-Oncology
Targepeutics Pipeline
Drug
Indication
Phase
GB-13
Glioblastoma (GBM) and Diffuse Midline Glioma (DMG)
Pre-clinical
Leadership Team at Targepeutics
LM
Lynn Maines, PhD
Co-founder, Business Development and Operations Advisor
RS
Randy Schrecengost, PhD
Chief Scientific Officer
View full Targepeutics profile